RU99117383A - COMPOSITION OF ANTIARRHYTHMIC MEDICINE - Google Patents

COMPOSITION OF ANTIARRHYTHMIC MEDICINE

Info

Publication number
RU99117383A
RU99117383A RU99117383/14A RU99117383A RU99117383A RU 99117383 A RU99117383 A RU 99117383A RU 99117383/14 A RU99117383/14 A RU 99117383/14A RU 99117383 A RU99117383 A RU 99117383A RU 99117383 A RU99117383 A RU 99117383A
Authority
RU
Russia
Prior art keywords
amount
per tablet
composition
components
polyvinylpyrrolidone
Prior art date
Application number
RU99117383/14A
Other languages
Russian (ru)
Other versions
RU2169556C2 (en
Inventor
Владимир Викторович Нестерук
Кирилл Константинович Сыров
Олег Эдуардович Кедровский
Original Assignee
Владимир Викторович Нестерук
Кирилл Константинович Сыров
Олег Эдуардович Кедровский
Filing date
Publication date
Application filed by Владимир Викторович Нестерук, Кирилл Константинович Сыров, Олег Эдуардович Кедровский filed Critical Владимир Викторович Нестерук
Priority to RU99117383/14A priority Critical patent/RU2169556C2/en
Priority claimed from RU99117383/14A external-priority patent/RU2169556C2/en
Application granted granted Critical
Publication of RU2169556C2 publication Critical patent/RU2169556C2/en
Publication of RU99117383A publication Critical patent/RU99117383A/en

Links

Claims (1)

Композиционный состав антиаритмического лекарственного средства Кардиодарон, включающий компоненты, совпадающие с компонентами аналога - амиодарона гидрохлорид в количестве 200,0 мг на одну таблетку, лактоза, поливинилпирролидон, отличающийся тем, что содержит следующие ингредиенты - тальк молотый в количестве 4,0 мг на одну таблетку, крахмал картофельный в количестве 60,0 мг на одну таблетку, целлюлоза микрокристаллическая в количестве 29,0 мг на одну таблетку, кальция стеарат в количестве 10,0 мг на одну таблетку, также отличающийся количественным содержанием компонентов - лактоза в количестве 90,0 мг на одну таблетку, поливинилпирролидон в количестве 7,0 мг на одну таблетку.The composition of the antiarrhythmic drug Cardiodarone, including components that match the components of the analogue - amiodarone hydrochloride in an amount of 200.0 mg per tablet, lactose, polyvinylpyrrolidone, characterized in that it contains the following ingredients - talcum powder in an amount of 4.0 mg per tablet , potato starch in an amount of 60.0 mg per tablet, microcrystalline cellulose in an amount of 29.0 mg per tablet, calcium stearate in an amount of 10.0 mg per tablet, also differing in amounts nnym content of components - lactose in the amount of 90.0 mg per tablet, polyvinylpyrrolidone in an amount of 7.0 mg per tablet.
RU99117383/14A 1999-08-16 1999-08-16 Composition formulation of antiarrhythmic medicinal agent RU2169556C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU99117383/14A RU2169556C2 (en) 1999-08-16 1999-08-16 Composition formulation of antiarrhythmic medicinal agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU99117383/14A RU2169556C2 (en) 1999-08-16 1999-08-16 Composition formulation of antiarrhythmic medicinal agent

Publications (2)

Publication Number Publication Date
RU2169556C2 RU2169556C2 (en) 2001-06-27
RU99117383A true RU99117383A (en) 2001-08-20

Family

ID=20223733

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99117383/14A RU2169556C2 (en) 1999-08-16 1999-08-16 Composition formulation of antiarrhythmic medicinal agent

Country Status (1)

Country Link
RU (1) RU2169556C2 (en)

Similar Documents

Publication Publication Date Title
MY136318A (en) Sustained-release tablet composition
CA2622805A1 (en) Compressed tablets comprising valsartan
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
CA2199778A1 (en) Extended release formulation of venlafaxine
ZA979220B (en) New oxadiazoles, processes for their preparation and their use as pharmaceutical compositions.
ZA200301813B (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
ZA200110217B (en) Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application.
HUP0204170A3 (en) 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
IL145661A0 (en) Pregelatinized starch in a controlled release formulation
IL156662A0 (en) Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
GEP20063882B (en) Dosage regimen and pharmaceutical composition for emergency contraception
WO2005007137A3 (en) Tablets containing ambroxol
RU93058535A (en) TABLET CONTAINING KOLESTIPOL HYDROCHLORIDE AND METHOD FOR PRODUCING IT
HUP0301228A3 (en) 3-azabicyclo(3.1.0)hexane derivatives having opioid receptor affinity, process for their preparation and pharmaceutical compositions containing them
HUP0202736A3 (en) Substituted aromatic-ring compounds, process for producing the same, and pharmaceutical compositions containing them and use thereof
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
RU99117383A (en) COMPOSITION OF ANTIARRHYTHMIC MEDICINE
CA2379887A1 (en) Stable tablets comprising simvastatin
BRPI0211439B8 (en)
EP1234834A4 (en) 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
CA2285852A1 (en) Pharmaceutical tablet comprising lisinopril disodium and microcrystalline cellulose
RU2000115604A (en) COMPOSITION OF ANTIBACTERIAL MEDICINE
HUP0202594A3 (en) Streptogramin derivatives, production thereof and pharmaceutical compositions containing the same
CA2473718A1 (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone